| Variable | n = 47 (%) |
| Median age (range) | 60 yrs (33 - 84 yrs) |
| Histology |
|
| High grade serous | 36 (77%) |
| Mucinous | 2 (4%) |
| Endometrioid | 5 (11%) |
| Clear cell | 2 (4%) |
| Low grade serous | 1 (2%) |
| Undifferentiated | 1 (2%) |
| Mean preoperative CA125 (range) | 1061 U/mL (21 - 5217 U/mL) |
| Mean preoperative albumin (range) | 3.3 g/dL (1.4 - 4.7 g/dL) |
| FIGO stage |
|
| IIb | 3 (7%) |
| IIIa | 2 (4%) |
| IIIb | 0 (0%) |
| IIIc | 33 (70%) |
| IV | 9 (19%) |
| Cytoreduced to less than 1 cm | 38 (81%) |
| Platinum sensitivity |
|
| Platinum sensitive > 12 months PFI | 24 (51%) |
| Platinum sensitive 6 - 12 months PFI | 7 (15%) |
| Platinum resistant | 4 (8%) |
| Platinum refractory | 5 (11%) |
| Unknown/Insufficient information | 7 (15%) |
| Median follow up (range) | 31 months (0.4 - 104 months) |
| Number of recurrences | 25 (53%) |
| Lost to follow up | 7 (15%) |
| Median months to recurrence (range) | 15 months (0 - 104 months) |